A psychology professor discusses Alzheimer’s disease signs and symptoms and the caregiving experience on television show “Second Opinion.”
The FDA's approval of Epiliodex could open the door for increased research of cannabis-based therapies, says UAB researcher.
More than a third of people have the biology of Alzheimer’s disease but not the symptoms. Understanding why could lead to new therapies.
The Blazer Bolt for Brain Cancer boasts record attendance as it raises money for brain tumor research
UAB investigators are looking at the intriguing possibility of a connection between the gut microbiome and Parkinson’s disease.
Cheryl Freeman, material transfer specialist in the Office of the Vice President for Research, is UAB’s Employee of the Month for September.
Four medical specialties are ranked in the top 20 in the nation, and six more are ranked in the top 50.
Investigators note that the use of CBD oil led to both fewer and less intense seizures for patients with intractable epilepsy in landmark study.
With electronic-cigarette use on the rise, doctoral student Abdullah Alanazi and Eric Ford, Ph.D., professor in the School of Public Health, want to understand the trend’s relationship with drug use — and is using UAB’s informatics framework for translational research to do it.
There’s no evidence-based consensus on how long a seizure-ridden patient should be kept in an artificial coma to enable the brain to recover. Wolfgang Muhlhofer, M.D., an assistant professor of neurology, wants to change that.
